The SARS-CoV-2 main protease as drug target
Loading...
Date
Authors
Ullrich, Sven
Nitsche, Christoph
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a severe disease associated with significant mortality. Several vaccine development and drug discovery campaigns are underway. The SARS-CoV-2 main protease is considered a promising drug target, as it is dissimilar to human proteases. Sequence and structure of the main protease are closely related to those from other betacoronaviruses, facilitating drug discovery attempts based on previous lead compounds. Covalently binding peptidomimetics and small molecules are investigated. Various compounds show antiviral activity in infected human cells.
Description
Keywords
antivirals, covid-19, coronavirus, peptidomimetics, protease inhibitors, amino acid sequence, animals, antiviral agents, betacoronavirus, cell line, coronavirus 3c proteases, cysteine endopeptidases, cysteine proteinase inhibitors, drug discovery, humans, peptidomimetics, sars-cov-2, substrate specificity, viral nonstructural proteins
Citation
Collections
Source
Bioorganic & medicinal chemistry letters
Type
Book Title
Entity type
Access Statement
Open Access
License Rights
CC BY-NC-ND
Restricted until
Downloads
File
Description
Main article